Molecular pathogenesis and mechanisms of thyroid cancer

TLDR: This work focuses on thyroid cancer, where the elucidation of the fundamental role of several major signalling pathways and related molecular derangements and central to these mechanisms are mutation, gene copy-number gain and aberrant gene methylation.

Abstract: Thyroid cancer is a common endocrine malignancy. There has been exciting progress in understanding its molecular pathogenesis in recent years, as best exemplified by the elucidation of the fundamental role of several major signalling pathways and related molecular derangements. Central to these mechanisms are the genetic and epigenetic alterations in these pathways, such as mutation, gene copy-number gain and aberrant gene methylation. Many of these molecular alterations represent novel diagnostic and prognostic molecular markers and therapeutic targets for thyroid cancer, which provide unprecedented opportunities for further research and clinical development of novel treatment strategies for this cancer.